secwatch.observer — SEC 8-K summary
======================================

Issuer:     4D Molecular Therapeutics, Inc. (FDMT)
CIK:        0001650648
Form:       8-K
Filed at:   2026-06-22T20:21:25+00:00
Accession:  0001193125-26-277563
Event type: other_material
Sentiment:  neutral
Materiality: 0.05
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

4D Molecular Therapeutics annual meeting: all director nominees elected, auditor and say-on-pay approved.
--------------------------------------------------------------------------------

- Directors elected: Nancy Miller-Rich (35.9M for, 1.2M withheld), John Milligan (35.8M for, 1.3M withheld), Shawn Tomasello (30.5M for, 6.6M withheld). Broker non-votes ~7.0M.
- Ratification of PwC as auditor: 43.9M for, 55.8K against, 81.9K abstain.
- Advisory say-on-pay approved: 36.1M for, 940K against, 67.4K abstain, 7.0M broker non-votes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1650648/000119312526277563/0001193125-26-277563-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1650648/000119312526277563/fdmt-20260617.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-277563

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer